Graduated third in my class at NYU School of Commerce in 1962, tops in Public Accounting; non-practicing CPA, former corporate manager, now sole owner of a publisher of magazines for stamp collectors, and a small investor.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
Beginning in 1994, Warren joined Goldman Sachs Asset Management. Following five years in New York, Warren transferred down to GSAM's Growth Equity team in Tampa, FL. Over the course of the next 15 years, Warren became a Portfolio Manager across several products including GSAM's Flexible Cap Growth fund (small to large capitalizations), Growth Opportunities Fund (mid cap) and Capital Growth Fund (large cap). From May 2013 to February 2015, Warren was at Logan Circle Partners as a Managing Director and Portfolio Manager. He was responsible for investments across various sectors including financials, services, technology and consumer discretionary. In 2015, Warren created Manole Capital Management and he currently runs this boutique investment manager.
Leveraging his accounting background from Lehigh University, Warren received his Certified Public Accountant license in 1998. In 2004, Warren received the Chartered Financial Analyst designation.
- MD, MBA (NYU-Stern, Finance specialization). Certificate in financial modeling (Wharton).
**Tipranks doesn't reflect my investment picks accurately since it doesn't pick up my premium service ratings.
- Founder: Vasuda Healthcare Analytics, premium research service covering emerging biotech/ pharma companies (www.research-biotechstocks.com).
- Founder, Trident Asian Research (www.tridentasia.com)
- Investment insights contributor: SumZero, Buy-side Institutional Platform (sumzero.com). Members of the platform include some of the largest hedge funds and asset managers.
-Former Insight Provider for Smartkarma Intelligent Investing (www.smartkarma.com): Institutional Investments Research Platform (was ranked among top 10 out of over 100 contributors). Clients included some of the largest hedge funds and asset managers.
- Buy-side equity research analyst covering mainly small-cap, emerging pharma/ biotech companies. M.D. with over 18 years of clinical experience (in the U.S. and India), still retaining full medical license in India. M.B.A. with finance and financial markets specialization from New York University Stern School of Business.
- Expert in picking healthcare-related investments, especially biotechnology and pharmaceuticals (focus on small, emerging companies). Investments are selected based on detailed due diligence, including proprietary DCF valuation models. Value investor with long-term horizon.
- Founder, managing principal of Vasuda Capital Management, healthcare-focused investment management firm, vasudacapitalmanagement.com. Registered Investment Advisor in Massachusetts.
- Also started and continue to sponsor Vasuda Global Orphan/ Rare disease biotechnology index, the first global equity index covering rare/orphan disease sector. Index quotes are available on bloomberg/reuters terminals.
I am currently in my 4th year of Bachelor of Engineering in the Engineering Physics discipline with specializations in Nanotechnology and Micro-Electrical-Mechanical Systems. It’s no secret the discipline and specialization I have pursued is not as popular as the Mechanical and Electrical Discipline, and why would it be? Who would want to spend several thousands of hours of reading literature, running simulations and performing labs on topics as new as tandem organic photovoltaic architectures, CMOS fabrication process, quantum mechanical processes in modern devices, while still having to be virtually as competent as our counterparts in electrical, software and computer? Well the answer is approximately 40 of the 1500 or so engineers graduating next year. One thing that all these students have in common, including myself, besides the obvious sleep deprivation and copious caffeine consumption is the tenacity to not sleep till anything and everything that comes our way has been mastered. With that being said, I approach my research with the same rigor and thoroughness I have become accustomed to over the past four years. In conclusion, I aim to bring my best independent thought to the readers as I would expect being an investor myself.
During the IPO season Francis Gaskins, editor of IPOdesktop.com & director of research for Equities.com, regularly appears on CNBC TV, Bloomberg, thestreet.com & other financial cable channels. On the day of the Visa IPO he appeared on four cable TV financial shows including Bloomberg & CNBC.
Over the past five years he has been quoted over 500 times by such financial media as the Wall Street Journal, Bloomberg, Reuters, Associated Press, USA Today among others. Those quotes are available at IPOdesktop.com.
His varied personal interests include violin playing. For example, he is concertmaster of the Palisades Symphony. He also holds an MBA from Harvard Business School (finance) and an AB from Princeton University (economics).
Don Dion (firstname.lastname@example.org, @DRDInvestments) is the owner and Chief Investment Officer of DRD Investments, LLC, based in Naples, FL. and Williamstown, MA., a family office focused on managing a long/short hedge fund, real estate assets, venture capital, and various other financial assets for the Dion family. Don no longer manages money for other families or institutions after selling Dion Money Management to NYC-based Focus Financial Partners in September of 2007 prior to the Great Recession. Don remains one of the largest individual shareholders of Focus Financial Partners. Mr. Dion is the managing trustee of the Dion Family Foundation, which focuses on helping individuals with tuition assistance at Catholic Institutions for grammar school, high school, and college education. The foundation also helps individuals by supporting health care institutions, particularly Massachusetts General Hospital. Don is on three leadership and advisory committees at Massachusetts General Hospital and the Home Base Program (a partnership between Mass General and the Red Sox Foundation). Don consults with Saint Dominic's Academy and served on the executive committee as a trustee of Saint Michaels College. In addition, Mr. Dion is the retired publisher of the Fidelity Independent Adviser (http://www.fidelityadviser.com/) family of newsletters, which provided a broad range of investor commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 90,000 subscribers in the United States and 29 other countries, Fidelity Independent Adviser published two monthly newsletters and one weekly newsletter. Its flagship publication, Fidelity Independent Adviser, was published monthly for 16 years and reached over 60,000 subscribers. Mr. Dion is the sole founder and retired C.E.O. of Dion Money Management (http://www.dionmm.com/), a fee-based investment advisory firm for affluent individuals, families and nonprofit organizations, where he was responsible for setting investment policy, creating custom portfolios, and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Massachusetts and Naples, FL., Dion Money Management managed over $900 million in assets for clients in 49 states and 11 countries, He fortunately sold the company to Focus Financial Partners on September 1, 2007 prior to the Great Recession. Mr. Dion was the Chairman and C.E.O. of Litchfield Financial Corp. "LTCH" a NASDAQ listed company which he founded with Summit Partners in 1988. LTCH went public in 1992 and was acquired by Textron Corp. "TXT" in 1999 for $183M of cash consideration. Don was the Executive Vice President, C.F.O., shareholder and General Counsel for Bluegreen Corp. "BXG" a NYSE company from 1986 to 1988. Mr. Dion graduated with honors from Saint Michaels College in 1976 with a B.S. degree in Economics and Business Administration. He received his J.D. degree from the University of Maine Law School in 1979 and his LL.M. degree from Boston University Law School in 1982. After law school, Mr Dion was employed as a tax and estate planning lawyer with the Boston firm of Warner and Stackpole from 1983 to 1985 and Ernst and Young as a C.P.A. from 1979 to 1983. Recently, Don has been spending some of his time researching and strategizing about IPOs, building on his prior experience of successfully taking companies public and six strong years of U.S. IPO returns (2009 to 2015). Mr. Dion can be reached at email@example.com.
Blogger on Seeking Alpha
Ranked #61 out of 5,308 bloggers (#154 of 9,385 overall experts)
290 out of 495
If you copied Don Dion's ratings since 2013 and opened each position for the duration of 1 Year , then 59% of your transactions would have been profitable with an average return of +7.7%.
Finance professional with extensive experience analyzing companies. I have an innate passion for finance and investing. While most popular stock prognosticators tell investors what they want to hear, I try to inform investors about what they need to know to make an informed decision.
Disclaimer: Articles and/or comments represent the opinion of the author, who is not a licensed financial advisor. Articles are intended for informational and educational purposes only, and should not be construed as investment advice to any particular individual. Readers should perform their own due diligence before making any investment decisions.
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs. Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy. Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc. Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client. Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.
I'm a capital projects manager and process design engineer at a large-cap biotech company. I love the financial world because it is like one big puzzle and I hope we the Seeking Alpha Community help each other out to solve the puzzle to help us realize our dreams.
Elephant Analytics has an Bachelor of Business Administration degree with a concentration in marketing and finance, and 13 years of experience as an analyst. Elephant Analytics originally focused on marketing and sales analysis due to geographical and lifestyle considerations, but rekindled his interest in finance and investing several years ago and became a contributor to Seeking Alpha in 2013. He has a particular interest in attempting to understand distressed companies and distressed industries.
Elephant Analytics has unique skills in the areas of numerical analysis and applied mathematics. Elephant Analytics achieved a top 50 score on the Bloomberg Aptitude Test (out of nearly 200,000 test takers) which measures financial aptitude. Elephant Analytics also has achieved a score (153) in the 99.98th percentile on the WAIS-III IQ test and has also been involved in multiple teams that have won awards during business and strategy competitions involving numerical analysis. In one such competition, he captained his team to become North American champions, ahead of MBA and undergraduate teams from universities such as Harvard, Yale and Northwestern.
Legal Disclaimer: Elephant Analytics' reports, premium research service and other writings are personal opinions only and should not be considered as investment advice. Only registered investment advisors can provide personalized investment advice. While Elephant Analytics attempts to provide reports that include accurate facts, investors should do their own diligence and fact checking prior to making their own decisions.
I'm a research analyst and financial journalist in Portland, OR. As an trained economist and former senior tech industry professional at IBM and Intel, I have broad experience evaluating market trends and identifying new business opportunities. More recently, I've been a senior advisor to venture-backed start-ups in the Pac NW. I leverage my core research/analysis skills in managing several private investment portfolios. I am also involved in biotech research through a non-profit initiative.
Selerity Research is a proprietary commentary & research service for financial professionals. Our team of highly experienced event analysts provide timely and relevant commentary and analysis on market-moving events related to everything from corporate earnings to key economic data announcements.
At StockSaints, we believe the best edge presents opportunity when discipline and timing are allowed to flourish, developing a systematic approach to capital allocation. Variables outside of any given company may influence entire sectors and industries in ways that warrant great care and consideration. With over 50 years of combined market insight, we are uniquely positioned to share our full understanding of the mechanics of the auction marketplace, the emotion and crowd psychology that drives prices, and the methods that produce repeatable results over time. Each trade has two parties, you and your counter-party, only one is correct in their decision.
Grant Zeng has over 10 years of professional experience in equity research and analysis. Grant joined Zacks Investment Research Inc. in March 2006, and currently is a senior equity analyst covering biotech/pharma industry. Before joining Zacks, Grant worked for TheStreet.com as a biotech analyst from 2005-2006. From Sept 2001 to December 2003, Grant worked for China Pacific Insurance Co. as an senior equity/fund analyst. Grant was a healthcare equity analyst with Young & Partners, LLC from Aug 2000 to September 2001. Grant had also teaching and researching experience in pharmaceutical science.
Grant Zeng obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He also holds a Master of Science in Biochemistry from the University of Western Ontario, Canada; Master of Pharmacology and Bachelor of Medicine from Second Military Medical University, China.
Grant Zeng is a Chartered Financial Analyst (CFA) charter holder.
I hold a PhD in Electrical Engineering (Control Theory) from Stanford University and a Masters Degree in Engineering-Economic Systems (now called Management Science and Engineering at Stanford).
I have been fascinated by the stock market since I was 14 (that is 37 years ago at writing). It has always struck me as the place to be.
In the last 10+ years I moved from what I would call the "herd mentality" to a more educated process. In particular, my years as a Principal Software Engineer in a derivatives software development company, interacting closely with Financial Engineers, showed me clearly the simple science behind this: "Mean Reversion is All We Know about the Game!"
I am an electronics exporter and private investor in various IT enterprises in India. I have a Bachelor's degree in electrical engineering and have been trading the markets for the last 2 decades.
RedChip's long history of success includes the first to issue independent research coverage on Starbucks in 1992. Other names RedChip discovered as they were on the cusp of becoming Blue-Chip stocks were: Nike™, MarketWatch.com™, Daktronics™.
Over the years, RedChip has evolved into a full-service financial public relations firm, representing hundreds of NASDAQ, NYSE and AMEX companies. The RedChip platform is the most comprehensive platform available today for emerging growth companies.
Headquartered in Orlando, Florida, with affiliate offices in San Francisco, Seoul, and Pittsburgh, RedChip reaches hundreds of thousands of investors simultaneously with its robust platform of services and products.
Small-Cap Equity Research, Financial Public Relations/Investor Relations, Achieving Fair Equity Value for Public Companies, Institutional and Retail Non-Deal Road Shows
Dr. Price writes about stocks, options, and the financial markets every weekday on Real Money Pro, a subscription site at The Street, and here, with Arrow Loop Partners at Seeking Alpha.
Paul has been a speaker at the International Traders Expo in New York City and the Options and Forex Expo in Las Vegas. He also gives investment seminars for subscribers of The Street's multiple subscription sites.
Dr. Price is also a featured contributor for Guru Focus.com, and here on Seeking Alpha.
Bill Simpson has been trading for a living since the late '90's, focusing on initial public offerings in the aftermarket -- and with great success (up an annualized average of 32% since 2000). His strength is analyzing upcoming offerings with a focus on determining and estimating potential market fair value before it opens for trading. Mr. Simpson's outstanding, indepth IPO reports are an important component of Seeking Alpha's IPO coverage.
Bill Simpson's subscription-based research is available on his site:
Friedrich is the name given to our algorithm for analyzing companies that trade on the global stock markets. In creating Friedrich we concentrated on analyzing each company’s Main Street operations through various established ratios, along with our own unique ratios that we developed over the last 30 years. What we came up with is a final "Main Street" price per share based on Generally Accepted Accounting Principles (GAAP), which is a framework of accounting standards, rules and procedures defined by the professional accounting industry, which has been adopted by nearly all publicly traded U.S. companies. We feel that our Main Street price result is what each company would need to trade at in order to be attractive to a businessperson on Main Street looking to buy at a bargain.
Since the only constant in the universe is change, the results for each company fluctuate by varying degrees. No company is an island unto itself, but each operates in a world of constant change and at times in areas where Chaos is the norm. By analyzing a company’s Main Street operations over time, Friedrich is able to give the potential investor a decade long analysis (opinion) as well as offering a Trailing Twelve Month (TTM) analysis (opinion), as well. Thus our readers will not only get as close to a real time view of operations on Main Street as is possible, but then can measure the consistency of the company’s operations over time to determine if s/he should invest or not.
Through our Friedrich algorithm we can analyze ten years of Balance Sheet, Income Statement and Cash Flow Statement data for each company all at once and generate one final result in seconds. Friedrich was designed to be ultra-conservative and thus will cut zero slack to any company under analysis and will do so with zero emotion. Companies must be exceptional in order to get an attractive Main Street valuation and the ideal investments according to our backtesting are the ones that have been consistent over time.
By being so ultra conservative Friedrich is designed to identify bargains that Wall Street investors may have overlooked. Companies shares may trade on the stock market but the companies themselves operate on Main Street, so Friedrich is designed to generate a Main Street price per share first and only then does he go to Wall Street and see the price for which Benjamin Graham’s “Mr. Market” is offering the shares.
Jiang is not a value investor nor a growth investor. He believes that it does not matter if a cat is black or white, as long as it catches mice.
Jiang has a BSc in Management from Lally School of Management at Rensselaer Polytechnic Institute, and an MBA from Rotman School of Management at University of Toronto.
Chinese Internet/Media: AMAP, BIDU, CTRIP, DANG, FMCN, LONG, JOBS, RENN, SINA, SOHU, SPRD, VNET, YOKU
NA Tech/Media/Telecom: AAPL, AMZN, EBAY, FB, GOOG, GRPN, KYAK, LNKD, NFLX, PCLN, RIMM, T
NA Consumer Staple/Discretionary: CMG, COH, KO, LULU, MCD, SBUX, TIF, YUM
Special Situation: F, TSLA, EDU
Renaissance Capital is an IPO investment advisory firm providing pre-IPO institutional research and management of IPO-focused funds including the Renaissance IPO ETF (NYSE ticker: IPO), the Renaissance International IPO ETF (NYSE ticker: IPOS) and the Global IPO Mutual Fund (ticker: IPOSX). Through Renaissance Capital’s pre-IPO research service, investors get a hard-nosed, independent opinion, in-depth fundamental analysis and customizable financial models on all IPOs. The Firm's clients also gain access to the premier IPO knowledge base with deal calendars, market commentary, fundamental data on over 5,000 past IPOs and more.
I am an an entrepreneur, trader and programmer based in Mainz, Germany. I studied economics, journalism and ethnology at the Jonannes Gutenberg University, Mainz. My experience with financial websites goes back to the late 1990s when I published a German language site (redboerse.de) focusing on emerging technology stocks. To me, work must be enjoyable.
"The mind is like a parachute. It doesn't work if it is not open." (Frank Zappa)
Here are a couple of my original ideas:
Small Cap Tech
Rediff (REDF): Recommended buy at less than $2 in August 2010. Within 1.5 months of my recommendation it touched $6. It is currently trading at $9.39.
Demand Media (DMD): Recommended Shorting at $16 in April 2011. Stock is at $7.51 now.
Anixter recommended at $40 on july 15,2010. Gave 50% plus return in 6 months.
Terex recommended at $22 on sept 20, 2010 and Gave 70% return in next 4 months.
Email me at firstname.lastname@example.org if you have any queries.
Mark's mutual fund is launching December 15, 2011.
He is a self taught private investor who operates the website Fund My Mutual Fund (http://fundmymutualfund.com); a daily mix of market, economic, and stock specific commentary. Fascinated by the market since an early age, he discovered mutual funds as a teenager in the 80s and moved to equities by the mid 90s. The origin of the website is/was to leverage the power of the internet in developing a transparent track record to attract investors for his potential "long/short" mutual fund.
His equity focus is identifying secular growth trends and the companies most likely to benefit from these macro trends. Stocks are identified through fundamental analysis, although basic technical analysis is used in determining entry and exit points. You can receive Trader Mark's latest posts daily by subscribing free via RSS reader (http://feeds.feedburner.com/FundMyMutualFund) or subscribing free via email (http://www.feedburner.com/fb/a/emailverifySubmit?feedId=1109639).
With a degree in economics from the University of Michigan, a broader understanding of the economy as a whole, along with interpreting investor psychology, is also a major interest for Mark. To follow on Twitter, username: fundmyfund